Manfrini N. et al.
RNA-processing proteins regulate Mec1/ATR activation by promoting generation of RPA-coated ssDNA
EMBO Rep. 2015

Grünewald TGP. et al.
Chimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatellite.
Nature Genetics (2015)
doi: 10.1038/ng.3363

Sanulli S. et al.
Jarid2 Methylation via the PRC2 Complex Regulates H3K27me3 Deposition during Cell Differentiation
Mol. Cell.
doi: 10.1016/j.molcel.2014.12.020

Laureau, R. et al.
Extensive Recombination of a Yeast Diploid Hybrid through Meiotic Reversion
PLoS Genetics.
doi: 10.1371/journal.pgen.1006283

Tourneau, C.L et al.
Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial
Lancet Oncol.
doi: 10.1016/S1470-2045(15)00188-6

Euceda LR. et al.
Metabolic response to Everolimus in patient-derived triple-negative breast cancer xenografts.
J Proteome Res. (2017) May. 16(5):1868-1879.
doi: 10.1021/acs.jproteome.6b00918

Portoso M. et al.
PRC2 is dispensable for HOTAIR-mediated transcriptional repression.
EMBO J. (2017) Apr. 36(8):981-994.
doi: 10.15252/embj.201695335

Perez-Rico YA. et al.
Comparative analyses of super-enhancers reveal conserved elements in vertebrate genomes.
Genome Res. (2017) Feb. 27(2):259-268.
doi: 10.1101/gr.203679.115

Greenberg MV. et al.
Transient transcription in the early embryo sets an epigenetic state that programs postnatal growth.
Nat Genet. (2017) Jan. 49(1):110-118.
doi: 10.1038/ng.3718

Chauvin C. et al.
High-throughput drug screening identifies Pazopanib and Clofilium Tosylate as promising treatments for Malignant Rhabdoid Tumors.
Cell Rep. (2017) Nov. 21(7):1737-1745.
doi: 10.1016/j.celrep.2017.10.076